The role of glatiramer acetate in the early treatment of multiple sclerosis
David W BrandesHope MS Center, Knoxville, TN, USA; ULCA, Los Angeles, CA, USAAbstract: The treatment of the underlying disease process causing multiple sclerosis has continued to evolve since the initial approval of interferon-beta-1b in 1993. Current emphasis is on early treatment, including treatm...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2010-06-01
|
| Series: | Neuropsychiatric Disease and Treatment |
| Online Access: | http://www.dovepress.com/the-role-of-glatiramer-acetate-in-the-early-treatment-of-multiple-scle-a4565 |
| _version_ | 1819292256910180352 |
|---|---|
| author | David W Brandes |
| author_facet | David W Brandes |
| author_sort | David W Brandes |
| collection | DOAJ |
| description | David W BrandesHope MS Center, Knoxville, TN, USA; ULCA, Los Angeles, CA, USAAbstract: The treatment of the underlying disease process causing multiple sclerosis has continued to evolve since the initial approval of interferon-beta-1b in 1993. Current emphasis is on early treatment, including treatment after a single clinical attack (clinically isolated syndrome). The assessment of which disease modifying medication to use as initial therapy has continued to remain a combination of science and the art of medicine. Equally important are the assessment of treatment failure and the subsequent choice of medication change. This article will present scientific information, as well as information about clinical decision making, about these choices, with emphasis on the changing role of glatiramer acetate in this process.Keywords: glatiramer acetate, early treatment, multiple sclerosis |
| first_indexed | 2024-12-24T03:51:39Z |
| format | Article |
| id | doaj.art-61356ac105164c298ae585332c41ab39 |
| institution | Directory Open Access Journal |
| issn | 1176-6328 1178-2021 |
| language | English |
| last_indexed | 2024-12-24T03:51:39Z |
| publishDate | 2010-06-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Neuropsychiatric Disease and Treatment |
| spelling | doaj.art-61356ac105164c298ae585332c41ab392022-12-21T17:16:33ZengDove Medical PressNeuropsychiatric Disease and Treatment1176-63281178-20212010-06-012010Issue 1329336The role of glatiramer acetate in the early treatment of multiple sclerosisDavid W BrandesDavid W BrandesHope MS Center, Knoxville, TN, USA; ULCA, Los Angeles, CA, USAAbstract: The treatment of the underlying disease process causing multiple sclerosis has continued to evolve since the initial approval of interferon-beta-1b in 1993. Current emphasis is on early treatment, including treatment after a single clinical attack (clinically isolated syndrome). The assessment of which disease modifying medication to use as initial therapy has continued to remain a combination of science and the art of medicine. Equally important are the assessment of treatment failure and the subsequent choice of medication change. This article will present scientific information, as well as information about clinical decision making, about these choices, with emphasis on the changing role of glatiramer acetate in this process.Keywords: glatiramer acetate, early treatment, multiple sclerosishttp://www.dovepress.com/the-role-of-glatiramer-acetate-in-the-early-treatment-of-multiple-scle-a4565 |
| spellingShingle | David W Brandes The role of glatiramer acetate in the early treatment of multiple sclerosis Neuropsychiatric Disease and Treatment |
| title | The role of glatiramer acetate in the early treatment of multiple sclerosis |
| title_full | The role of glatiramer acetate in the early treatment of multiple sclerosis |
| title_fullStr | The role of glatiramer acetate in the early treatment of multiple sclerosis |
| title_full_unstemmed | The role of glatiramer acetate in the early treatment of multiple sclerosis |
| title_short | The role of glatiramer acetate in the early treatment of multiple sclerosis |
| title_sort | role of glatiramer acetate in the early treatment of multiple sclerosis |
| url | http://www.dovepress.com/the-role-of-glatiramer-acetate-in-the-early-treatment-of-multiple-scle-a4565 |
| work_keys_str_mv | AT davidwbrandes theroleofglatirameracetateintheearlytreatmentofmultiplesclerosis AT davidwbrandes roleofglatirameracetateintheearlytreatmentofmultiplesclerosis |